{"transactions":[{"id":2349605,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":129497,"kind":"person","name":"Colao Massimilano","position":1,"cik":"0001837645","reported_name":"Colao Massimilano","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-04T21:11:51.000Z","date":"2022-03-02","kind":"grant","acquired":true,"shares":178063,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter."}],"balance_after":178063,"derivative":{"exercise_price":12.01,"expiration_date":"2032-03-02","underlying":"Common Stock","underlying_shares":178063},"source":{"system":"sec-edgar","filing":"0001628280-22-005124","document":"wf-form4_164642829060367.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828022005124/wf-form4_164642829060367.xml","form_type":"4"}},{"id":2349604,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":129497,"kind":"person","name":"Colao Massimilano","position":1,"cik":"0001837645","reported_name":"Colao Massimilano","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-03-04T21:11:51.000Z","date":"2022-03-02","kind":"grant","acquired":true,"shares":104080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in three (3) equal annual installments beginning March 2, 2022, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in three (3) equal annual installments beginning March 2, 2022, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in three (3) equal annual installments beginning March 2, 2022, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date."}],"balance_after":104080,"derivative":{"underlying":"Common Shares","underlying_shares":104080},"source":{"system":"sec-edgar","filing":"0001628280-22-005124","document":"wf-form4_164642829060367.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828022005124/wf-form4_164642829060367.xml","form_type":"4"}},{"id":2349603,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":129497,"kind":"person","name":"Colao Massimilano","position":1,"cik":"0001837645","reported_name":"Colao Massimilano","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-03-04T21:11:51.000Z","date":"2022-03-02","kind":"sale","acquired":false,"shares":3205,"price":12.01,"value":38492.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares sold to cover tax withholding obligations in connection with the vesting of Performance Awards."}],"balance_after":13495,"source":{"system":"sec-edgar","filing":"0001628280-22-005124","document":"wf-form4_164642829060367.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828022005124/wf-form4_164642829060367.xml","form_type":"4"}},{"id":2349602,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":129497,"kind":"person","name":"Colao Massimilano","position":1,"cik":"0001837645","reported_name":"Colao Massimilano","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-03-04T21:11:51.000Z","date":"2022-03-02","kind":"grant","acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 18, 2021, the Reporting Person was granted stock based performance awards (\"Performance Awards\") which vests when specific performance metrics are met based on the results for the year ended December 31, 2021. It was determined that as of March 2, 2022, the Reporting Person partially met the performance criteria and received shares of common stock for no consideration."}],"balance_after":16700,"source":{"system":"sec-edgar","filing":"0001628280-22-005124","document":"wf-form4_164642829060367.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828022005124/wf-form4_164642829060367.xml","form_type":"4"}}]}